Ptc Therapeutics (PTCT) Other Non-Current Assets (2012 - 2026)

Ptc Therapeutics' Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $21.6 million for Q2 2026.

• In Q2 2026, Other Non-Current Assets fell 0.92% year-over-year to $21.6 million; the TTM figure through Jun 2026 stood at $21.6 million (down 0.92% YoY), while the FY2025 annual figure was $18.3 million, down 11.6% from the prior year.
• Other Non-Current Assets for Q2 2026 stood at $21.6 million, down from $22.6 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $60.3 million in Q2 2022, with the low at $18.3 million in Q4 2025.
• The 5-year median for Other Non-Current Assets is $24.9 million (2024), against an average of $32.3 million.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets grew 7.85% in 2023, then slumped 48.73% in 2024.
• Ptc Therapeutics' Other Non-Current Assets stood at $48.6 million in 2022, then decreased by 25.39% to $36.2 million in 2023, then tumbled by 42.88% to $20.7 million in 2024, then fell by 11.6% to $18.3 million in 2025, then advanced by 17.92% to $21.6 million in 2026.
• Business Quant data shows PTCT's Other Non-Current Assets at $21.6 million in Q2 2026, $22.6 million in Q1 2026, and $18.3 million in Q4 2025.